EP0840600A1 - Timbre transdermique contenant de l'aspirine - Google Patents

Timbre transdermique contenant de l'aspirine

Info

Publication number
EP0840600A1
EP0840600A1 EP96927180A EP96927180A EP0840600A1 EP 0840600 A1 EP0840600 A1 EP 0840600A1 EP 96927180 A EP96927180 A EP 96927180A EP 96927180 A EP96927180 A EP 96927180A EP 0840600 A1 EP0840600 A1 EP 0840600A1
Authority
EP
European Patent Office
Prior art keywords
adhesive
patch
transdermal patch
aspirin
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96927180A
Other languages
German (de)
English (en)
Inventor
William Byrne
Dermot Mccafferty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cal International Ltd
Original Assignee
Cal International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cal International Ltd filed Critical Cal International Ltd
Publication of EP0840600A1 publication Critical patent/EP0840600A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Timbre transdermique contenant de l'aspirine utilisé comme un produit actif sur le plan pharmaceutique qui a pour propriété de laver les plaquettes. Le timbre comprend un support, un adhésif pour coller le timbre et une pellicule à retirer lorsqu'on colle le timbre. L'aspirine est intégrée à l'adhésif.
EP96927180A 1995-07-27 1996-07-26 Timbre transdermique contenant de l'aspirine Withdrawn EP0840600A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IE950575 1995-07-27
IE950575 1995-07-27
IE960368 1996-05-27
IE960368 1996-05-27
PCT/IE1996/000049 WO1997004759A1 (fr) 1995-07-27 1996-07-26 Timbre transdermique contenant de l'aspirine

Publications (1)

Publication Number Publication Date
EP0840600A1 true EP0840600A1 (fr) 1998-05-13

Family

ID=26319840

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96927180A Withdrawn EP0840600A1 (fr) 1995-07-27 1996-07-26 Timbre transdermique contenant de l'aspirine

Country Status (6)

Country Link
EP (1) EP0840600A1 (fr)
JP (1) JPH11510157A (fr)
AU (1) AU6709196A (fr)
CA (1) CA2228034A1 (fr)
GB (1) GB2319473A (fr)
WO (1) WO1997004759A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19616539A1 (de) * 1996-04-25 1997-11-06 Luitpold Pharma Gmbh Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel
JPH1112177A (ja) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
DE19959913A1 (de) * 1999-12-11 2001-06-28 Lohmann Therapie Syst Lts Acetylsalicylsäure enthaltendes transdermales System zur Behandlung von Migräne
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
FR2926466B1 (fr) * 2008-01-23 2010-11-12 Dbv Tech Procede de fabrication de patchs par electrospray
WO2011076401A1 (fr) 2009-12-23 2011-06-30 Holger Schankin Compositions pharmaceutiques sensiblement exemptes d'eau, contenant de l'acide acétylsalicylique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP921157A2 (en) * 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9704759A1 *

Also Published As

Publication number Publication date
GB9801409D0 (en) 1998-03-18
JPH11510157A (ja) 1999-09-07
AU6709196A (en) 1997-02-26
CA2228034A1 (fr) 1997-02-13
WO1997004759A1 (fr) 1997-02-13
GB2319473A (en) 1998-05-27

Similar Documents

Publication Publication Date Title
RU2450805C2 (ru) Трансдермальная терапевтическая система
JP2542026B2 (ja) 平担な治療装置及びその製法
CA2125662C (fr) Systeme a administration transdermique contenant de l'acide acetylsalicylique pour le traitement de la thrombose et la prophylaxie du cancer
US5202125A (en) Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
JP3924008B2 (ja) アンギオテンシン転換酵素(ace)阻害剤を含有する経皮的に適用可能な薬剤
JP6391664B2 (ja) リバスチグミンを含む、経皮薬物送達システム
EP1225951A2 (fr) Systeme de relargage double de medicaments par voie transdermique a couches adhesives
KR920010392B1 (ko) 경피투여용 약학 조성물의 제조방법
JPH0725669B2 (ja) 経皮投与用医薬製剤
WO1997004759A1 (fr) Timbre transdermique contenant de l'aspirine
US5068103A (en) Salbutamol-containing plaster and method of producing same
JP2003520191A (ja) 薬物の親水性塩類を含有する感圧接着剤マトリックスパッチの製造方法
JPH04217919A (ja) エペリゾンまたはトルペリゾン経皮吸収製剤
WO1999062557A1 (fr) Composition destinee a une administration transdermique de medicaments anti-inflammatoires non steroidiens
IE960540A1 (en) A formulation
KR100322988B1 (ko) 소염진통첩부제조성물및이를함유한소염진통첩부제
WO1997004758A1 (fr) Preparation pharmaceutique pour absorption percutanee
JP2869167B2 (ja) 徐放性貼付製剤
IE960539A1 (en) Pharmaceutical preparation for percutaneous absorbtion
JP3799502B2 (ja) 抗血栓治療および癌予防のためのアセチルサリチル酸を含有する経皮投与システム
JP2006169160A (ja) 外用貼付剤およびその製造方法
EP0944384B1 (fr) Systeme d'administration de medicaments transdermiques pour le traitement des maladies du coeur
WO1997004757A1 (fr) Formulation transdermique a base de nitrate
JPH05294832A (ja) 経皮吸収貼付剤
KR20010010664A (ko) 진양 첩부제 조성물 및 경피투여시스템

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980126

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000201